-
RRBS MDACC Lung PreCancer
Study
EGAS00001004610
-
Targeted exome sequencing of pleomorphic invasive lobular carcinoma (PILC).
Study
EGAS00001002871
-
Combined targeting of BRD4-associated Promoter Activation and NFKB Immunomodulation in ARID1A-mutated Gastric Adenocarcinoma
Study
EGAS00001006397
-
Foundation Medicine Genomic Data Used to Identify Prognostic Markers and Fusion Genes in Multiple Myeloma
Study
EGAS00001002874
-
Recapitulation of genetic predisposition to medulloblastoma in human neuroepithelial stem cells
Study
EGAS00001003620
-
Single cell RNA sequencing of lung adenocarcinoma.
Study
EGAS00001003681
-
Robust detection of translocations in lymphoma FFPE samples using Targeted Locus Capture-based sequencing - NGS targeted capture control cohort
Study
EGAS00001005325
-
MGA-NUTM1 fusion in high grade spindle cell sarcoma
Study
EGAS00001003341
-
WGS and WES of pediatric osteosarcoma
Study
EGAS00001003342
-
A novel TP53-KPNA3 translocation defines a de novo treatment-resistant clone in osteosarcoma
Study
EGAS00001001805
-
Genomic Heterogeneity and the Small Renal Mass
Study
EGAS00001002919
-
Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
Study
EGAS00001002928
-
RNAseq of 76 samples from Uveal Melanoma tumors
Study
EGAS00001002932
-
Mutational Patterns in Metastatic Cutaneous Squamous Cell Carcinoma
Study
EGAS00001003370
-
Cancer and germline exomes consisting of FASTQ paired-end reads from melanoma and lung cancer samples
Study
EGAS00001003723
-
Single cell copy number and chromatin accessibility in primary multiple myeloma cells
Study
EGAS00001005382
-
Integrated Genomic, Epigenetic, and Expression Analyses of Ovarian Cancer Cell Lines
Study
EGAS00001002998
-
Biallelic tumor suppressor loss and DNA repair defects in de novo small cell prostate cancer
Study
EGAS00001003007
-
DNA Methylation loss coupled with mitotic cell division promotes immune evasion of tumours with high mutation load
Study
EGAS00001003731
-
CCND1-negative MCL
Study
EGAS00001003060
-
Ewings Sarcoma RNA-Seq
Study
EGAS00001003062
-
Whole Exome Sequencing of 60 tumor/normal matched liver Cancers (HCC)
Study
EGAS00001003063
-
Tissue and plasma RNA from esophageal cancer and precursor lesions
Study
EGAS00001004939
-
Feasibility Study to Identify the Optimal Adjuvant Combination Scheme of Ipilimumab and Nivolumab (OpACIN) in resectable stage III melanoma patients
Study
EGAS00001003099
-
Clinical genome sequencing uncovers potentially targetable truncations and fusions of MAP3K8 in spitzoid and other melanomas
Study
EGAS00001003430
-
DERMATLAS__Myopericytoma
Study
EGAS00001006676
-
whole-genome sequencing in 17 ESCC cases and whole-exome sequencing in 71 cases
Study
EGAS00001000709
-
Targeted_sequencing_of_cylindroma_patients
Study
EGAS00001002708
-
Biomarker Screen for Efficacy of Oncolytic Virotherapy in Patient-derived Pancreatic Cancer Cultures
Study
EGAS00001007001
-
MutWP1__CRUK_Grand_Challenge__matched_blood_Nanoseq
Study
EGAS00001006774
-
CAF-S3 subset in human breast and ovarian cancers
Study
EGAS00001003344
-
Gene expression profile of mesothelial-derived carcinoma-associated fibroblasts
Study
EGAS00001003747
-
NRG1 Fusions in KRAS Wild-type Pancreatic Cancer (H021)
Study
EGAS00001002759
-
WES of melanoma tumors treated with combined immune checkpoint blockade
Study
EGAS00001003857
-
Identification of rare germline variants in familial multiple myeloma
Study
EGAS00001004734
-
DIPG RNA and exome sequencing
Study
EGAS00001004749
-
Subtype specific progression from DCIS to invasive breast cancer
Study
EGAS00001001866
-
Exome sequencing of a novel cervical cancer cell line
Study
EGAS00001003343
-
Targeted panel data for newly diagnosed myeloma patients.
Study
EGAS00001002859
-
Genomic Profiling of Thyroid Cancer Reveals a Role for Thyroglobulin in Metastasis -Part II
Study
EGAS00001003357
-
Normal brain controls for ICGC PedBrain DNA methylation sequencing
Study
EGAS00001000909
-
Growth Hormone (GH) -secreting Pituitary Adenoma
Study
EGAS00001003488
-
Alveolar Rhabdomyosarcoma case report
Study
EGAS00001004828
-
The_contribution_of_POT1_variants_to_sporadic_melanoma_development
Study
EGAS00001001964
-
Mutational patterns and regulatory networks in epigenetic subgroups of meningioma (H033)
Study
EGAS00001003481
-
Immune trajectory of response and adverse effect in immunotherapy-treated hepatocellular carcinoma
Study
EGAS00001004843
-
Therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastoma
Study
EGAS00001004550
-
Whole genome and whole transcriptome sequencing of Hepatosplenic T Cell Lymphoma tumor.
Study
EGAS00001003775
-
Tumor-derived cell lines as pharmacogenomic models to predict therapeutic vulnerabilities in hepatocellular carcinoma
Study
EGAS00001003536
-
RNA-seq of Ewing sarcoma tumors (ICGC)
Study
EGAS00001003333